Parallel Arm Trial of AD109 and AD504 In Patients With OSA
Trial details
- Registry ID
- NCT05071612
- Phase
- Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Parallel Arm Trial of AD109 and AD504 In Patients With OSANCT05071612 | Apnimed | Phase 2 | Completed | 2022-07-20Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |